Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Harnett

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Medical Journal of Australia|May 11, 2001
Should doctors wear white coats?P R Harnett
The Medical Journal of Australia|November 7, 1994
Euthanasia: attitudes and practices of medical practitionersP R Harnett
American Journal of Clinical Oncology|June 1, 1996
Adenocarcinoma of the duodenum with liver metastases. Complete remission and long-term survival with 5-fluorouracil chemotherapy--a case reportM Witham, P R Harnett
Australian and New Zealand Journal of Medicine|August 1, 1993
Vertebral osteomyelitis in advanced breast cancerA Goldrick, P R Harnett
Biochemical Pharmacology|October 18, 1994
Heterogeneous repair of platinum-DNA adducts by protein extracts from mammalian tissuesS L Jones, P R Harnett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
"But doctor, what have i got to lose...?"P R Harnett, T J Moynihan
Progress in Clinical and Biological Research|January 1, 1986
Drug resistance in the clinical situationM H Tattersall, P R Harnett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Drug resistance in clinical practice: patterns of treatment failure in advanced breast and ovarian cancerP R Harnett, F Kirsten, M H Tattersall
Cancer Chemotherapy and Pharmacology|October 11, 2001
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopeniaA D Guminski, P R Harnett, A deFazio
Journal of Clinical Epidemiology|January 1, 1996
A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index--cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30)M T King, A J Dobson, P R Harnett
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Medical Journal of Australia|May 11, 2001
Should doctors wear white coats?P R Harnett
The Medical Journal of Australia|November 7, 1994
Euthanasia: attitudes and practices of medical practitionersP R Harnett
American Journal of Clinical Oncology|June 1, 1996
Adenocarcinoma of the duodenum with liver metastases. Complete remission and long-term survival with 5-fluorouracil chemotherapy--a case reportM Witham, P R Harnett
Australian and New Zealand Journal of Medicine|August 1, 1993
Vertebral osteomyelitis in advanced breast cancerA Goldrick, P R Harnett
Biochemical Pharmacology|October 18, 1994
Heterogeneous repair of platinum-DNA adducts by protein extracts from mammalian tissuesS L Jones, P R Harnett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
"But doctor, what have i got to lose...?"P R Harnett, T J Moynihan
Progress in Clinical and Biological Research|January 1, 1986
Drug resistance in the clinical situationM H Tattersall, P R Harnett
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Drug resistance in clinical practice: patterns of treatment failure in advanced breast and ovarian cancerP R Harnett, F Kirsten, M H Tattersall
Cancer Chemotherapy and Pharmacology|October 11, 2001
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopeniaA D Guminski, P R Harnett, A deFazio
Journal of Clinical Epidemiology|January 1, 1996
A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index--cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30)M T King, A J Dobson, P R Harnett
Pageof 3